Clinical Trials Browser

Unrecognized Condition × liposomal doxorubicin × Other neoplasm × Clear all

NCT04213612 2019-12-30

DCV in the Treatment of Recurrence and Refractory Childhood Solid Tumors

Phase 1 Unknown

Unrecognized Condition